Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Articles tagged with "REF News"

A Journey Begins with the First Step

David I. Daikh, MD, PhD  |  

The ACR Research and Education Foundation (REF) has launched the Action Alliance network, a program that calls on rheumatologists, investigators, and health professionals to join the REF in asking patients and families to be a part of the conversation. The Action Alliance consists of two programs working together: From the Field Speakers Bureau and Patients and Families for Progress.

Setting Goals for Future Growth

  |  

Perhaps the most personally rewarding aspect of working with the ACR Research and Education Foundation (REF) is seeing the success that can come from setting lofty goals. First and foremost, the REF is a goal-oriented organization. The staff and volunteers are not only committed to the goal of ensuring the future of rheumatology, but they aspire to reach high and to lead in this effort.

Student Benefits from Resident Research Preceptorship

  |  

Although the ACR Research and Education Foundation offers a number of opportunities to students interested in rheumatology, the Ephraim P. Engleman Endowed Resident Research Preceptorship is a unique opportunity that allows for a much more in-depth learning experience. The purpose of the Engleman Preceptorship is to introduce residents to the specialty of rheumatology by supporting a full-time research experience, with the goal of attracting promising physician–scientists to the field of rheumatology early in their careers.

New ACR and ARHP Leaders Join the Ranks

  |  

The ACR is pleased to welcome new and returning leaders to the ACR board of directors and ARHP executive committee who were appointed in November. The following members were selected to serve as the newest members-at-large of the ACR board of directors. Each of them shared what they will bring to the table.

Naturally Occurring Antibodies May Lead to New RA Therapies

  |  

A study published in the Journal of Immunology indicates that naturally occurring antibodies in the human immune system have the capacity to suppress inflammatory responses throughout the body. These antibodies may provide researchers an opportunity to develop new therapies for rheumatoid arthritis (RA) and other inflammatory conditions using similar pathways.

Research Tracks Possible Benefit of Src-like Adaptor Protein

  |  

A study recently submitted for publication has demonstrated that manipulating T-cell receptor complex–mediated signaling can prevent the development of autoimmune arthritis in mice and may lead to new human therapies without the drawbacks associated with existing treatments.